Replies to post #95225 on Amarantus Bioscience Holdings Inc (AMBS)

[WarpCore61]

I replied to your previous post before seeing your correction to my post, which I also identified and acknowledged in my reply.

So are we in agreement the new deal will result in and additional 37.5M shares vs. the old deal?

I believe this is a good move given the additional time needed to determine the true value of LymPro before any partnership or licensing deal is stuck. I feel much better knowing the company now has funding though 2014 with provisions in place for additional funding until commercialization of LymPro.

I just hope there's additional news to move the share price a lot higher before the up-list, as I'd rather see a smaller vs. a larger RS. (Note: this is not intended to start another discussion of reverse splits. I'm simply stating my preference, and wanting my shares reduced as little as possible).